LWM
HALO icon

Liberty Wealth Management’s Halozyme HALO Stock Holding History

Liberty Wealth Management’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-300
Closed -$12K – 555
2021
Q3 		$12K Hold
300
– – ﹤0.01% 786
2021
Q2 		$14K Hold
300
– – 0.01% 578
2021
Q1 		$14K Hold
300
– – 0.01% 524
2020
Q4 		$14K Buy
+300
New +$10.8K 0.01% 521

Other funds holding HALO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
SCM
Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Liberty Wealth Management's HALO Position: Q4 2021 in Review

Liberty Wealth Management sold out of Halozyme (HALO) in Q4 2021, closing a stake of 300 shares — an estimated $12K sold.

Liberty Wealth Management first reported a position in HALO in Q4 2020 and held it in 4 quarters. The position peaked at $14K in Q2 2021. 324 funds tracked by Wall St. Rank hold HALO as of Q4 2021.

  • Liberty Wealth Management reported no remaining Halozyme position as of Q4 2021 after selling out during the quarter.
  • Liberty Wealth Management sold 300 Halozyme shares in Q4 2021, an estimated $12K.
  • Liberty Wealth Management first reported a position in Halozyme in Q4 2020 and held it in 4 quarters.
  • Liberty Wealth Management's Halozyme position peaked at $14K in Q2 2021.
  • 324 funds tracked by Wall St. Rank held Halozyme as of Q4 2021.

Based on Liberty Wealth Management's 13F filing for Q4 2021, filed 15 Feb 2022.